Advertisement
Screener

HARVARD BIOSCIENCE, INC. (HBIO) Disposal Group, Including Discontinued Operation, Revenue

1.6 / 5 stars · 26/82 Roast Me

HARVARD BIOSCIENCE, INC. Disposal Group, Including Discontinued Operation, Revenue

HARVARD BIOSCIENCE, INC. (HBIO) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-08.

Discontinued › Income Statement › Other Income

us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2019-11-08

  • HARVARD BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
  • HARVARD BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for fiscal 2018 was $893.00K, a 96.35% decline from fiscal 2017.
  • HARVARD BIOSCIENCE, INC. disposal group, including discontinued operation, revenue for fiscal 2017 was $24.48M.
Period endDisposal Group, Including Discontinued Operation, Revenue 3 monthDisposal Group, Including Discontinued Operation, Revenue 6 monthDisposal Group, Including Discontinued Operation, Revenue 9 monthDisposal Group, Including Discontinued Operation, Revenue 12 month
2019-03-31$0.00
10-Q · filed 2019-05-08
$0.00
derived: sum of 2 quarters · filed 2019-05-08
$0.00
derived: sum of 3 quarters · filed 2019-05-08
$0.00
derived: sum of 4 quarters · filed 2019-08-08
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$0.00
derived: sum of 2 quarters · filed 2019-03-18
$0.00
derived: sum of 3 quarters · filed 2019-08-08
$893.00K
10-K · filed 2019-03-18
2018-09-30$0.00
10-Q · filed 2018-11-01
$0.00
derived: sum of 2 quarters · filed 2019-08-08
$893.00K
10-Q · filed 2019-11-08
$6.71M
derived: sum of 4 quarters · filed 2019-08-08
2018-06-30$0.00
10-Q · filed 2019-08-08
$893.00K
10-Q · filed 2019-08-08
$6.71M
derived: sum of 3 quarters · filed 2019-08-08
$13.04M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$893.00K
10-Q · filed 2019-05-08
$6.71M
derived: sum of 2 quarters · filed 2019-05-08
$13.04M
derived: sum of 3 quarters · filed 2019-05-08
$19.30M
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$5.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$12.15M
derived: sum of 2 quarters · filed 2019-03-18
$18.41M
derived: sum of 3 quarters · filed 2019-03-18
$24.48M
10-K · filed 2019-03-18
2017-09-30$6.33M
10-Q · filed 2018-11-01
$12.59M
derived: sum of 2 quarters · filed 2018-11-01
$18.66M
10-Q · filed 2018-11-01
2017-06-30$6.25M
10-Q · filed 2018-08-02
$12.32M
10-Q · filed 2018-08-02
2017-03-31$6.07M
10-Q · filed 2018-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Precipio, Inc. (PRPO)United States$0.043B-36.70
Bionano Genomics, Inc. (BNGO)United States$0.020B-0.42
ASTROTECH Corp (ASTC)United States$0.013B
Seer, Inc. (SEER)United States$0.104B-1.34
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Quanterix Corp (QTRX)United States$0.150B-1.65
EyePoint, Inc. (EYPT)United States$0.314B-3.96
908 Devices Inc. (MASS)United States$0.476B-9.53
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15